Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. The Company has a portfolio of nine diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. PET and SPECT are imaging techniques in molecular nuclear diagnostics (MND) with applications in clinical oncology, cardiology, neurology and inflammatory/infectious diseases. Its commercial products include Gluscan/Gluscan 500/Barnascan, FluoroChol, MIBITEC/Adamibi, DOPAVIEW, Leukokit, Neurolite, SomaKit and NETSPOT. Additional MND product candidates include Annexin V-128, a SPECT product candidate for the imaging of apoptotic and necrotic lesions with potential applications in a range of indications.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Specialty & Advanced Pharmaceuticals
- Sub-Industry: N/A
- Symbol: NASDAQ:AAAP
- CUSIP: N/A
- Web: www.adacap.com
Capitalization:- Market Cap: $2.53434 billion
- Outstanding Shares: 44,166,000
Average Prices:- 50 Day Moving Avg: $50.30
- 200 Day Moving Avg: $41.43
- 52 Week Range: $23.50 - $60.99
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -2,885.00
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $148.26 million
- Price / Sales: 17.19
- Book Value: $7.76 per share
- Price / Book: 7.44
Profitability:- EBIDTA: ($20,010,000.00)
- Net Margins: -33.83%
- Return on Equity: -16.05%
- Return on Assets: -11.18%
Debt:- Current Ratio: 6.35%
- Quick Ratio: 6.10%
Misc:- Average Volume: 101,186 shs.
- Beta: 0.66
- Short Ratio: 0.95
Frequently Asked Questions for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)
What is Advanced Accelerator Applications S.A.'s stock symbol?
Advanced Accelerator Applications S.A. trades on the NASDAQ under the ticker symbol "AAAP."
How were Advanced Accelerator Applications S.A.'s earnings last quarter?
Advanced Accelerator Applications S.A. (NASDAQ:AAAP) posted its earnings results on Thursday, August, 31st. The company reported ($0.13) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.12) by $0.01. The firm had revenue of $40.14 million for the quarter, compared to analyst estimates of $36.74 million. Advanced Accelerator Applications S.A. had a negative return on equity of 16.05% and a negative net margin of 33.83%. View Advanced Accelerator Applications S.A.'s Earnings History.
When will Advanced Accelerator Applications S.A. make its next earnings announcement?
Where is Advanced Accelerator Applications S.A.'s stock going? Where will Advanced Accelerator Applications S.A.'s stock price be in 2017?
5 brokerages have issued 1-year target prices for Advanced Accelerator Applications S.A.'s stock. Their predictions range from $47.00 to $69.00. On average, they expect Advanced Accelerator Applications S.A.'s share price to reach $56.50 in the next year. View Analyst Ratings for Advanced Accelerator Applications S.A..
Who are some of Advanced Accelerator Applications S.A.'s key competitors?
Some companies that are related to Advanced Accelerator Applications S.A. include Mallinckrodt PLC (MNK), Supernus Pharmaceuticals (SUPN), Indivior PLC (INDV), Repligen Corporation (RGEN), TherapeuticsMD (TXMD), TherapeuticsMD (TXMD), Aimmune Therapeutics (AIMT), Eagle Pharmaceuticals (EGRX), Assembly Biosciences (ASMB), Rockwell Medical (RMTI), Novan (NOVN), Check-Cap (CHEK), CorMedix (CRMD), DARA Biosciences (DARA), Macrocure Ltd (MCUR) and Salix Pharmaceuticals (SLXP).
Who are Advanced Accelerator Applications S.A.'s key executives?
Advanced Accelerator Applications S.A.'s management team includes the folowing people:
- Claudio Costamagna, Chairman of the Board
- Stefano Buono, Chief Executive Officer, Founder, Director
- Heinz Mausli, Chief Financial Officer
- Gerard Ber, Chief Operating Officer
- Claude A. Hariton Ph.D., Head of Clinical Development
- Maurizio Franco Mariani, Global Head of Pre-Clinical Research
- Kapil Dhingra, Independent Director
- Steven R. Gannon, Independent Director
- Yvonne L. Greenstreet M.D., Independent Director
- Christian Merle, Independent Director
When did Advanced Accelerator Applications S.A. IPO?
(AAAP) raised $76 million in an initial public offering (IPO) on Thursday, February 5th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.
Who owns Advanced Accelerator Applications S.A. stock?
Advanced Accelerator Applications S.A.'s stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (9.80%), Artisan Partners Limited Partnership (1.24%), Vivo Capital LLC (0.00%), PointState Capital LP (0.00%), TD Asset Management Inc. (0.00%) and Alps Advisors Inc. (0.00%). View Institutional Ownership Trends for Advanced Accelerator Applications S.A..
Who sold Advanced Accelerator Applications S.A. stock? Who is selling Advanced Accelerator Applications S.A. stock?
Who bought Advanced Accelerator Applications S.A. stock? Who is buying Advanced Accelerator Applications S.A. stock?
How do I buy Advanced Accelerator Applications S.A. stock?
Shares of Advanced Accelerator Applications S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Advanced Accelerator Applications S.A.'s stock price today?
One share of Advanced Accelerator Applications S.A. stock can currently be purchased for approximately $57.70.
MarketBeat Community Rating for Advanced Accelerator Applications S.A. (NASDAQ AAAP)MarketBeat's community ratings are surveys of what our community members think about Advanced Accelerator Applications S.A. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating, 4 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.80) |
| Consensus Price Target: | $56.50 (2.08% downside) |
Analysts' Ratings History for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/1/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $50.00 -> $60.00 | Low |  |
| 7/27/2017 | JMP Securities | Upgrade | Market Perform -> Outperform | $69.00 | High | |
| 7/27/2017 | Canaccord Genuity | Set Price Target | Buy | $47.00 | Low | |
| 6/15/2017 | J P Morgan Chase & Co | Initiated Coverage | Overweight -> Overweight | $50.00 | High | |
| 11/29/2016 | Wells Fargo & Company | Downgrade | Outperform -> Market Perform | | N/A | |
| 3/16/2016 | Citigroup Inc. | Reiterated Rating | Neutral | $32.00 -> $36.00 | N/A | |
(Data available from 9/20/2015 forward)
Earnings History for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)Earnings History by Quarter for Advanced Accelerator Applications S.A. (NASDAQ AAAP)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/27/2017 | | ($0.17) | | | | | N/A | |
| 8/31/2017 | 6/30/2017 | ($0.12) | ($0.13) | $36.74 million | $40.14 million | View | N/A | |
| 3/23/2017 | 12/31/2016 | ($0.22) | ($0.18) | $30.10 million | $30.29 million | View | N/A | |
| 11/28/2016 | 9/30/2016 | ($0.09) | ($0.18) | $25.21 million | $30.03 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)Current Year EPS Consensus Estimate: $-0.75 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS
Dividend History for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)
Latest Headlines for Advanced Accelerator Applications S.A. (NASDAQ:AAAP)
| Source: |
|
| Date | Headline |
|---|
 | Head to Head Analysis: Advanced Accelerator Applications (AAAP) & Aimmune Therapeutics (AIMT)
www.americanbankingnews.com - September 18 at 12:28 AM |
| Zacks: Brokerages Expect Advanced Accelerator Applications S.A. (AAAP) to Post -$0.18 Earnings Per Share
www.americanbankingnews.com - September 16 at 4:22 AM |
| Head to Head Contrast: Advanced Accelerator Applications (AAAP) and Its Competitors
www.americanbankingnews.com - September 13 at 10:34 PM |
| Advanced Accelerator Applications S.A. (AAAP) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - September 9 at 9:08 AM |
| Financial Contrast: Aimmune Therapeutics (AIMT) & Advanced Accelerator Applications (AAAP)
www.americanbankingnews.com - September 8 at 10:30 AM |
 | Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lutetium Lu 177 Dotatate* (Lutathera®)
finance.yahoo.com - September 7 at 1:08 AM |
| Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017
finance.yahoo.com - September 7 at 1:08 AM |
 | Advanced Accelerator Applications (AAAP) in Focus: Stock Moves 7.5% Higher
www.zacks.com - September 6 at 3:02 PM |
 | CORRECTING and REPLACING -- Advanced Accelerator Applications S.A.
feeds.benzinga.com - September 6 at 12:32 PM |
| Advanced Accelerator Applications' (AAAP) Buy Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - September 1 at 5:54 PM |
| Advanced Accelerator Applications S.A. (AAAP) Announces Earnings Results
www.americanbankingnews.com - September 1 at 7:50 AM |
| Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017
finance.yahoo.com - August 31 at 3:09 PM |
 | 3 Things In Biotech You Should Learn Today: August 30, 2017
seekingalpha.com - August 30 at 8:05 PM |
| Advanced Accelerator Gets Action Date for Lutathera from FDA
finance.yahoo.com - August 29 at 8:22 PM |
| Advanced Accelerator Applications Announces New Prescription Drug User Fee Act (PDUFA) date of January 26, 2018, for Lutetium Lu 177 Dotatate (Lutathera®)
finance.yahoo.com - August 28 at 3:14 PM |
| Head to Head Contrast: Advanced Accelerator Applications (AAAP) and Eagle Pharmaceuticals (EGRX)
www.americanbankingnews.com - August 22 at 10:24 PM |
| Advanced Accelerator Applications S.A. (AAAP) to Release Earnings on Tuesday
www.americanbankingnews.com - August 22 at 1:56 AM |
| Advanced Accelerator Applications S.A. (AAAP) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - August 15 at 11:57 AM |
| Financial Comparison: Advanced Accelerator Applications (AAAP) versus Macrocure (MCUR)
www.americanbankingnews.com - August 14 at 6:12 PM |
| Analyzing NOVAN INC (NOVN) and Advanced Accelerator Applications (AAAP)
www.americanbankingnews.com - August 13 at 6:08 AM |
| Rockwell Medical (RMTI) & Advanced Accelerator Applications (NASDAQ:AAAP) Head-To-Head Survey
www.americanbankingnews.com - August 4 at 6:28 PM |
| Zacks.com featured highlights: Columbus McKinnon, The New York Times, Advanced Accelerator Applications, Enanta Pharmaceuticals and Caesars Entertainment
finance.yahoo.com - August 4 at 3:17 PM |
| Advanced Accelerator Applications: Lutathera Approval Looms
seekingalpha.com - August 2 at 3:03 PM |
| Advanced Accelerator Applications (AAAP) Rises: Stock Up 6.2%
www.zacks.com - August 2 at 3:03 PM |
| Advanced Accelerator Applications S.A. (AAAP) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - August 1 at 5:24 PM |
| Advanced Accelerator Applications S.A. (NASDAQ:AAAP) Upgraded to "Outperform" by JMP Securities
www.americanbankingnews.com - July 27 at 4:38 PM |
| Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA
finance.yahoo.com - July 27 at 3:08 PM |
| Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7%
finance.yahoo.com - July 25 at 3:08 PM |
 | Advanced Accelerator Applications (AAAP) Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide for GEP-NET Tumors
www.streetinsider.com - July 22 at 8:04 PM |
 | Advanced Accelerator Applications Announces Positive CHMP Opinion Recommending Approval of Lutetium
www.nasdaq.com - July 21 at 8:23 PM |
| Advanced Accelerator Applications Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide (Lutathera®) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors
finance.yahoo.com - July 21 at 3:19 PM |
| Advanced Accelerator Applications S.A. (NASDAQ:AAAP) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - July 21 at 8:54 AM |
| AbbVie (ABBV) vs. Advanced Accelerator Applications (NASDAQ:AAAP) Head-To-Head Comparison
www.americanbankingnews.com - July 20 at 8:42 AM |
 | South Asian Fintech Startups Find A Champion In This Emerging Market Accelerator
www.forbes.com - July 19 at 8:06 PM |
| Advanced Accelerator Applications S.A. (NASDAQ:AAAP) Raised to "Buy" at BidaskClub
www.americanbankingnews.com - July 16 at 11:40 AM |
| Advanced Accelerator Applications S.A. (NASDAQ:AAAP) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - July 11 at 6:02 PM |
| ETFs with exposure to Advanced Accelerator Applications SA : July 11, 2017
finance.yahoo.com - July 11 at 3:07 PM |
| ETFs with exposure to Advanced Accelerator Applications SA : June 27, 2017
finance.yahoo.com - June 27 at 3:17 PM |
| Advanced Accelerator Applications S.A. (AAAP) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - June 26 at 8:54 AM |
| Advanced Accelerator Applications S.A. (AAAP) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - June 24 at 12:06 AM |
| Advanced Accelerator Applications' (AAAP) Buy Rating Reaffirmed at Jefferies Group LLC
www.americanbankingnews.com - June 23 at 5:18 PM |
| Advanced Accelerator Applications S.A. (AAAP) Rating Lowered to D at TheStreet
www.americanbankingnews.com - June 18 at 11:28 PM |
| ETFs with exposure to Advanced Accelerator Applications SA : June 16, 2017
finance.yahoo.com - June 16 at 8:17 PM |
| Advanced Accelerator Applications S.A. (AAAP) Now Covered by Analysts at J P Morgan Chase & Co
www.americanbankingnews.com - June 15 at 2:02 PM |
| Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 14 at 3:02 PM |
| Blog Coverage Chembio Announces Major Leadership Shuffle as CEO Sperzel Takes Medical Leaves
finance.yahoo.com - June 2 at 3:13 PM |
| Canaccord Genuity Analysts Give Advanced Accelerator Application SA (AAAP) a $47.00 Price Target
www.americanbankingnews.com - June 1 at 11:02 PM |
 | BRIEF-Advanced Accelerator Applications' Q1 sales $34.9 million
www.reuters.com - May 31 at 11:47 AM |
| Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
finance.yahoo.com - May 31 at 11:47 AM |
| Advanced Accelerator Application SA (AAAP) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 30 at 8:47 AM |
Advanced Accelerator Applications S.A. (AAAP) Chart for Wednesday, September, 20, 2017
